ArticleScientific reports2024

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge.

Supavit Chesdachai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.